BioKey Positions Itself as a Strategic U.S. Pharmaceutical Platform Amid Global Tariff Shifts
ABVC BioPharma's subsidiary, BioKey, leverages its Silicon Valley manufacturing facility to meet global demand for compliant drug production, highlighting the importance of local infrastructure in the face of increasing tariffs and supply chain realignments.
